{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:51:59Z","timestamp":1793962319468,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:00:00Z","timestamp":1513123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:00:00Z","timestamp":1513123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent reports show that B7-H4 is highly expressed in a variety of tumor cells, functions as a negative regulator of T cells and then promotes tumor progression. However, its expression and role in intrahepatic cholangiocarcinoma (ICC) remain unclear. In present study, B7-H4 expression in ICC and peritumoral tissues was determined at the level of mRNA and protein, and its bioactivity in ICC cells was studied after modification of B7-H4 expression. Then, the mechanism related to tumor progression induced by B7-H4 expression in ICC cells was explored. Finally, clinical significance of B7-H4 expression in ICC patients was further analyzed. The results showed that B7-H4 expression in ICC was much higher than that in peritumoral tissues at the level of both mRNA and protein. The high level of B7-H4 in ICC cells induced epithelial-to-mesenchymal transitions and promoted invasion and metastasis of tumor cells through activation of ERK1\/2 signaling. The elevated B7-H4 expression was associated with the downregulated Bax, upregulated Bcl-2 expression, and activation of caspase-3. Clinically, high B7-H4 expression in tumor samples was significantly related to malignant phenotype, such as lymph node metastasis, high tumor stage, and poor differentiation. ICC patients with high expression of B7-H4 had shorter overall survival (OS) and disease-free survival. Moreover, the B7-H4 expression was an\u00a0independent prognostic factor for predicting OS and tumor recurrence of ICC patients after operation. In conclusion, high expression of\u00a0B7-H4\u00a0promotes tumor progression of ICC and\u00a0may be a novel therapeutic target for ICC patients.<\/jats:p>","DOI":"10.1038\/s41419-017-0015-6","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T10:30:25Z","timestamp":1513161025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Nan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Bin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Ji","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Mang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Wu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava, N & Gores, GJ. Cholangiocarcinoma. Lancet \n                           383, 2168\u20132179 (2014).","journal-title":"Lancet"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, LA et al. Global cancer statistics, 2012. CA Cancer J Clin \n                           65, 87\u2013108 (2015).","journal-title":"CA Cancer J Clin"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","volume":"56","author":"SA Khan","year":"2012","unstructured":"Khan, SA et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol \n                           56, 848\u2013854 (2012).","journal-title":"J Hepatol"},{"key":"15_CR4","first-page":"2892","volume":"19","author":"A Ruzzenente","year":"2015","unstructured":"Ruzzenente, A, Conci, S, Valdegamberi, A, Pedrazzani, C & Guglielmi, A Role of surgery in the treatment of intrahepatic cholangiocarcinoma. Eur Rev Med Pharmacol Sci \n                           19, 2892\u20132900 (2015).","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"46750","DOI":"10.18632\/oncotarget.8775","volume":"7","author":"DQ Chong","year":"2016","unstructured":"Chong, DQ & Zhu, AX The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. Oncotarget \n                           7, 46750\u201346767 (2016).","journal-title":"Oncotarget"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/hep.23953","volume":"52","author":"R Chinnadurai","year":"2010","unstructured":"Chinnadurai, R & Grakoui, A B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells. Hepatology \n                           52, 2177\u20132185 (2010).","journal-title":"Hepatology"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","volume":"18","author":"GL Sica","year":"2003","unstructured":"Sica, GL et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity \n                           18, 849\u2013861 (2003).","journal-title":"Immunity"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","volume":"53","author":"Y Sun","year":"2006","unstructured":"Sun, Y et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer \n                           53, 143\u2013151 (2006).","journal-title":"Lung Cancer"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/cncr.23566","volume":"113","author":"PL Crispen","year":"2008","unstructured":"Crispen, PL, Boorjian, SA, Lohse, CM, Leibovich, BC & Kwon, ED Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer \n                           113, 450\u2013460 (2008).","journal-title":"Cancer"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3892\/ol.2016.4128","volume":"11","author":"H Xu","year":"2016","unstructured":"Xu, H et al. B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer. Oncol Lett \n                           11, 1841\u20131846 (2016).","journal-title":"Oncol Lett"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MPA.0b013e31829695d2","volume":"43","author":"SS Cheung","year":"2014","unstructured":"Cheung, SS et al. B7-H4 expression in normal and diseased human islet beta cells. Pancreas \n                           43, 128\u2013134 (2014).","journal-title":"Pancreas"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-04-3550","volume":"66","author":"I Simon","year":"2006","unstructured":"Simon, I. et al. B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res \n                           66, 1570\u20131575 (2006).","journal-title":"Cancer Res"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1158\/1078-0432.CCR-04-1658","volume":"11","author":"B Tringler","year":"2005","unstructured":"Tringler, B et al. B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res \n                           11, 1842\u20131848 (2005).","journal-title":"Clin Cancer Res"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1158\/2326-6066.CIR-15-0100","volume":"3","author":"K Kreymborg","year":"2015","unstructured":"Kreymborg, K et al. Ablation of B7-H3 but not B7-H4 results in highly increased tumor burden in a murine model of spontaneous prostate cancer. Cancer Immunol Res \n                           3, 849\u2013854 (2015).","journal-title":"Cancer Immunol Res"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1477-7819-12-188","volume":"12","author":"H Shi","year":"2014","unstructured":"Shi, H et al. Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer. World J Surg Oncol \n                           12, 188 (2014).","journal-title":"World J Surg Oncol"},{"key":"15_CR16","doi-asserted-by":"crossref","first-page":"77237","DOI":"10.18632\/oncotarget.12628","volume":"7","author":"L Chen","year":"2016","unstructured":"Chen, L et al. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients. Oncotarget \n                           7, 77237\u201377243 (2016).","journal-title":"Oncotarget"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MPA.0b013e318150e4e0","volume":"36","author":"NS Awadallah","year":"2008","unstructured":"Awadallah, NS et al. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct,. Pancreas \n                           36, 200\u2013206 (2008).","journal-title":"Pancreas"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1053\/j.gastro.2011.02.008","volume":"140","author":"AW Ke","year":"2011","unstructured":"Ke, A W et al. CD151 amplifies signaling by integrin alpha6beta1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology \n                           140, 1629\u20131641 (2011).","journal-title":"Gastroenterology"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/hep.26255","volume":"57","author":"XY Huang","year":"2013","unstructured":"Huang, XY et al. alphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology \n                           57, 2235\u20132247 (2013).","journal-title":"Hepatology"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.canlet.2008.02.067","volume":"266","author":"H Song","year":"2008","unstructured":"Song, H et al. B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation. Cancer Lett \n                           266, 227\u2013237 (2008).","journal-title":"Cancer Lett"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1158\/1078-0432.CCR-15-0858","volume":"22","author":"Y Yao","year":"2016","unstructured":"Yao, Y et al. B7-H4(B7x)-mediated cross-talk between glioma-initiating cells and macrophages via the IL6\/JAK\/STAT3 pathway lead to poor prognosis in glioma patients. Clin Cancer Res \n                           22, 2778\u20132790 (2016).","journal-title":"Clin Cancer Res"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.23661","volume":"52","author":"GM Shi","year":"2010","unstructured":"Shi, GM et al. CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology \n                           52, 183\u2013196 (2010).","journal-title":"Hepatology"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1002\/cncr.25485","volume":"116","author":"XY Huang","year":"2010","unstructured":"Huang, XY et al. Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer \n                           116, 5440\u20135451 (2010).","journal-title":"Cancer"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.22639","volume":"49","author":"AW Ke","year":"2009","unstructured":"Ke, AW et al. Role of overexpression of CD151 and\/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology \n                           49, 491\u2013503 (2009).","journal-title":"Hepatology"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.18632\/oncotarget.6833","volume":"7","author":"AW Ke","year":"2016","unstructured":"Ke, AW et al. Generation and characterization of a tetraspanin CD151\/integrin alpha6beta1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC. Oncotarget \n                           7, 6314\u20136322 (2016).","journal-title":"Oncotarget"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-2567.2010.03364.x","volume":"132","author":"X Feng","year":"2011","unstructured":"Feng, X et al. Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumour necrosis factor alpha and growth arrest-specific gene 6. Immunology \n                           132, 287\u2013295 (2011).","journal-title":"Immunology"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/hep.27682","volume":"61","author":"JB Cai","year":"2015","unstructured":"Cai, JB et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatology \n                           61, 1603\u20131614 (2015).","journal-title":"Hepatology"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0015-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0015-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0015-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T18:53:39Z","timestamp":1671735219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0015-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1038\/s41419-017-0015-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,13]]},"assertion":[{"value":"12 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing financial interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"3205"}}